Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-20-007238
Filing Date
2020-08-10
Accepted
2020-08-10 09:13:42
Documents
69
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT tnxp-10q_063020.htm 10-Q 558297
2 PURCHASE AND SALE AGREEMENT, DATED JULY 1, 2020 ex10-01.htm EX-10.1 69052
3 ASSET PURCHASE AGREEMENT ex10-02.htm EX-10.02 151117
4 AMENDED AND RESTATED EXCLUSIVE LICENSE AGREEMENT ex10-03.htm EX-10.03 6245
5 ASSIGNMENT AND AGREEMENT ex10-04.htm EX-10.04 30859
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-01.htm EX-31.01 10623
7 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-02.htm EX-31.02 10562
8 CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER ex32-01.htm EX-32.01 6147
15 GRAPHIC ex9903001.jpg GRAPHIC 107627
16 GRAPHIC ex9903002.jpg GRAPHIC 96465
17 GRAPHIC ex9903003.jpg GRAPHIC 36065
  Complete submission text file 0001387131-20-007238.txt   4201092

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT tnxp-20200630.xml EX-101.INS 538455
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tnxp-20200630.xsd EX-101.SCH 49806
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tnxp-20200630_cal.xml EX-101.CAL 45314
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tnxp-20200630_def.xml EX-101.DEF 192314
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tnxp-20200630_lab.xml EX-101.LAB 356587
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tnxp-20200630_pre.xml EX-101.PRE 269742
Mailing Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36019 | Film No.: 201087432
SIC: 2834 Pharmaceutical Preparations